StockUS listing USNOVTNASDAQTechnologyProfitless Growth

Novanta Inc(NOVT) Stock Analysis | Technology

USD --+0.00%
Reward43Moderate
Risk56Medium-High
75%Data
Revenue growing 10% YoY
USD —+0.00 (+0.00%) Previous close · NASDAQ
Market cap 5.54Bn
Reward Rating43 Moderate reward assessment · 75% data coverage
Bottom 25% of stocksView factors
Risk Rating56 Medium-High risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on NOVT to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Novanta Inc?

, together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally.

AI Brief Pro

The brief on Novanta Inc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Novanta Inc?

, together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The company is listed on the NASDAQ in USA, operating in the Technology sector, with a market capitalisation of 5.54B, and a P/E ratio of 92.8x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Moderate volatility with meaningful macro and earnings sensitivity.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (43)

Similar stocks to compare

A short list of Scientific & Technical Instruments names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorTechnology
IndustryScientific & Technical Instruments
P/E Ratio92.7595
Beta1.675
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
16,500 shares
$845k
0
6-9months
734,303 shares
$4.5M
0
9-12months
0
0